COVID-19

News

Hepatitis drug could be tested against COVID-19 in India

India’s Zydus Cadila wants to test a form of interferon, usually used against hepatitis B and C, as a potential treatment for the virus that causes COVID-19.

News

Young sporty woman practicing yoga, doing upward facing dog exercise, Urdhva mukha shvanasana pose, working out, wearing sportswear, pants and top, indoor full length, white yoga studio

Lockdown sparks global yoga craze, digital health survey sho...

Digital health firm Withings has used its technology to produce a read-out of how COVID-19 lockdowns have affected the health of its users, showing a smaller than expected increase in weigh

News

First doses of Gilead's COVID-19 drug remdesivir to arrive a...

The first doses of Gilead’s COVID-19 drug remdesivir are set to arrive in US hospitals this week after the FDA said the medicine can be used to fight the coronavirus pandemic.

Views & Analysis

How virtual conferences are faring and how pharma can do better

What pharma can do to win in virtual

Early data indications from the first virtual congresses shows big changes are needed.

News

Amgen to test psoriasis pill Otezla in COVID-19

Amgen has announced it is developing its already marketed psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus.

News

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it cu

Hepatitis drug could be tested against COVID-19 in India

Lockdown sparks global yoga craze, digital health survey sho...

First doses of Gilead's COVID-19 drug remdesivir to arrive a...

What pharma can do to win in virtual

Amgen to test psoriasis pill Otezla in COVID-19

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

RNAi biotech City hauls in $200m in upsized IPO

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks